111 results on '"Gemici, Cengiz"'
Search Results
2. Risk of endocrine pancreatic insufficiency in patients receiving adjuvant chemoradiation for resected gastric cancer
3. A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey
4. Review of: "Radiation therapy‐associated toxicity: Etiology, management, and prevention"
5. Efficacy of Iodopovidone Pleurodesis and Comparison of Small-Bore Catheter Versus Large-Bore Chest Tube
6. Escitalopram co-prescription in anastrozole-treated breast cancer patients.
7. Covid-19 outbreak in a major radiation oncology department; which lessons should be taken?
8. CT Derived Hounsfield Unit: An Easy Way to Determine Osteoporosis and Radiation Related Fracture Risk in Irradiated Patients
9. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option
10. the Addition of Induction Chemotherapy to Preoperative, Concurrent Chemoradiotherapy Improves Tumor Response in Patients With Esophageal Adenocarcinoma
11. Akciğer SBRT Tedavisinde DIBH ve Abdomen Kompresör Kullanımının İntrafraksiyonel Kayma ile İlişkisinin Karşılaştırılması.
12. Meme Kanseri Radyoterapisinde İmmobilizasyonun Oar Etkisi.
13. Volumetric decrease of pancreas after abdominal irradiation, it is time to consider pancreas as an organ at risk for radiotherapy planning
14. Role of Stereotactic Radiotherapy in Cranial Metastases of Small Cell Lung Cancer.
15. Stereotactic Body Radiotherapy for Adrenal Gland Metastases: Single-Center Experience.
16. Jinekolojik Tümörler El Kitabı
17. Jinekolojik Tümörler Tanı Tedavi Takip
18. Osteoporosis and insufficiency fracture risk developing in cases with stomach cancer after adjuvant radiochemotherapy
19. Results of Treatment with Stereotactic Radiotherapy in Patients with Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
20. Radiation field size and dose determine oncologic outcome in esophageal cancer
21. Pretreatment SUVmax value to predict outcome in patients with stage III NSCLC receiving concurrent chemoradiotherapy.
22. Is there any role of intravenous iron for the treatment of anemia in cancer?
23. Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients
24. Results of Treatment with Stereotactic Radiotherapy in Early Stage Medically Inoperable Non Small Cell Lung Cancer Patients
25. Re-Irradiation of Progressive Brain Metastases After Whole Brain Radiotherapy: Outcome of Stereotactic Radiosurgery
26. Co-existence of gastrointestinal stromal tumors with other primary neoplasms
27. Whole-brain radiation therapy for brain metastases: detrimental or beneficial?
28. In Regard to Sahgal et al
29. Neuroendocrine/squamous gastric collision tumor: A rare entity
30. In Regard to Muijs et al
31. P-107 - Osteoporosis and insufficiency fracture risk developing in cases with stomach cancer after adjuvant radiochemotherapy
32. Treatment approaches for metastatic breast cancer in Turkey
33. Progression-Free Survival Benefit or Health-Related Quality-of-Life Advantage: Which One to Choose?
34. Cost Minimization Analysis of Docetaxel + Cisplatin + 5-Fu Vs Capecitabine + Cisplatin in Patients with Advanced Gastric Cancer
35. Lhermitte's sign: Review with special emphasis in oncology practice
36. Tumor Lysis Syndrome in Solid Tumors
37. How Can We Determine the Role of Radiotherapy in the Treatment of Localized Aggressive Non-Hodgkin's Lymphoma?
38. Erythropoietin to treat anaemia in patients with head and neck cancer
39. Is Liver Disease an Octreotide Side Effect?
40. SRS With or Without Whole-Brain Radiation Therapy for Those With 1 to 4 Brain Metastases: In Regard to Sahgal et al.
41. P-0092COST MINIMIZATION ANALYSIS OF DOCETAXEL + CISPLATIN + 5-FU VS CAPECITABINE + CISPLATIN IN PATIENTS WITH ADVANCED GASTRIC CANCER.
42. The Prognostic and Predictive Value of Expression of P-AKT in Patients with FIGO IIB Locally Advanced Cervical Cancer under Chemotherapy.
43. Radiation field size and dose determine oncologic outcome in esophageal cancer
44. Mide tümörlü hastalarda kemoradyoterapi sonrası radyoterapiye bağlı geç dönem renal komplikasyonlar ve buna ait klinik bulguların saptanması
45. Pretreatment SUV max value to predict outcome in patients with stage III NSCLC receiving concurrent chemoradiotherapy.
46. Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants.
47. Neuroendocrine/squamous gastric collision tumor: A rare entity.
48. Residual tumor after neoadjuvant chemoradiation outside the radiation therapy target volume: a new prognostic factor for survival in esophageal cancer: in regard to Muijs et al.
49. Co-existence of gastrointestinal stromal tumors with other primary neoplasms.
50. Endoscopic scoring of late gastrointestinal mucosal damage after adjuvant radiochemotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.